NM_170665.4(ATP2A2):c.1847C>T (p.Ala616Val) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 18, 2016
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000420542.1

Allele description [Variation Report for NM_170665.4(ATP2A2):c.1847C>T (p.Ala616Val)]

NM_170665.4(ATP2A2):c.1847C>T (p.Ala616Val)

Genes:

ATP2A2:ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [Gene - OMIM - HGNC]
LOC126861637:MED14-independent group 3 enhancer GRCh37_chr12:110778306-110779505 [Gene]

Variant type:

single nucleotide variant

Cytogenetic location:

12q24.11

Genomic location:

Preferred name:

NM_170665.4(ATP2A2):c.1847C>T (p.Ala616Val)

HGVS:

NC_000012.12:g.110340744C>T
NG_007097.2:g.64118C>T
NM_001681.4:c.1847C>T
NM_170665.4:c.1847C>TMANE SELECT
NP_001672.1:p.Ala616Val
NP_733765.1:p.Ala616Val
NC_000012.11:g.110778549C>T
NM_170665.3:c.1847C>T

Protein change:

A616V

Links:

dbSNP: rs1057522321

NCBI 1000 Genomes Browser:

rs1057522321

Molecular consequence:

NM_001681.4:c.1847C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_170665.4:c.1847C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000527140	GeneDx	criteria provided, single submitter (GeneDx Variant Classification (06012015))	Uncertain significance (Apr 18, 2016)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000527140

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification (06012015))

Uncertain significance
(Apr 18, 2016)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV000527140.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The A616V variant in the ATP2A2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A616V variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A616V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret A616V as a variant of uncertain significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 26, 2023

ClinVar

Relating variation to medicine